Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns

The spatial distribution of tumor infiltrating lymphocytes (TILs) defines several histologically and clinically distinct immune subtypes—desert (no TILs), excluded (TILs in stroma), and inflamed (TILs in tumor parenchyma). To date, robust classification of immune subtypes still requires deeper exper...

Full description

Bibliographic Details
Main Authors: Agata Mlynska, Jolita Gibavičienė, Otilija Kutanovaitė, Linas Senkus, Julija Mažeikaitė, Ieva Kerševičiūtė, Vygantė Maskoliūnaitė, Neda Rupeikaitė, Rasa Sabaliauskaitė, Justina Gaiževska, Karolina Suveizdė, Jan Aleksander Kraśko, Neringa Dobrovolskienė, Emilija Paberalė, Eglė Žymantaitė, Vita Pašukonienė
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/14/2/171
_version_ 1797298745793052672
author Agata Mlynska
Jolita Gibavičienė
Otilija Kutanovaitė
Linas Senkus
Julija Mažeikaitė
Ieva Kerševičiūtė
Vygantė Maskoliūnaitė
Neda Rupeikaitė
Rasa Sabaliauskaitė
Justina Gaiževska
Karolina Suveizdė
Jan Aleksander Kraśko
Neringa Dobrovolskienė
Emilija Paberalė
Eglė Žymantaitė
Vita Pašukonienė
author_facet Agata Mlynska
Jolita Gibavičienė
Otilija Kutanovaitė
Linas Senkus
Julija Mažeikaitė
Ieva Kerševičiūtė
Vygantė Maskoliūnaitė
Neda Rupeikaitė
Rasa Sabaliauskaitė
Justina Gaiževska
Karolina Suveizdė
Jan Aleksander Kraśko
Neringa Dobrovolskienė
Emilija Paberalė
Eglė Žymantaitė
Vita Pašukonienė
author_sort Agata Mlynska
collection DOAJ
description The spatial distribution of tumor infiltrating lymphocytes (TILs) defines several histologically and clinically distinct immune subtypes—desert (no TILs), excluded (TILs in stroma), and inflamed (TILs in tumor parenchyma). To date, robust classification of immune subtypes still requires deeper experimental evidence across various cancer types. Here, we aimed to investigate, define, and validate the immune subtypes in melanoma by coupling transcriptional and histological assessments of the lymphocyte distribution in tumor parenchyma and stroma. We used the transcriptomic data from The Cancer Genome Atlas melanoma dataset to screen for the desert, excluded, and inflamed immune subtypes. We defined subtype-specific genes and used them to construct a subtype assignment algorithm. We validated the two-step algorithm in the qPCR data of real-world melanoma tumors with histologically defined immune subtypes. The accuracy of a classifier encompassing expression data of seven genes (immune response-related: <i>CD2</i>, <i>CD53</i>, <i>IRF1</i>, and <i>CD8B</i>; and stroma-related: <i>COL5A2</i>, <i>TNFAIP6</i>, and <i>INHBA</i>) in a validation cohort reached 79%. Our findings suggest that melanoma tumors can be classified into transcriptionally and histologically distinct desert, excluded, and inflamed subtypes. Gene expression-based algorithms can assist physicians and pathologists as biomarkers in the rapid assessment of a tumor immune microenvironment while serving as a tool for clinical decision making.
first_indexed 2024-03-07T22:40:27Z
format Article
id doaj.art-3217e8fb3c2a402ca0ab8edb71b07c56
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-07T22:40:27Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-3217e8fb3c2a402ca0ab8edb71b07c562024-02-23T15:09:17ZengMDPI AGBiomolecules2218-273X2024-01-0114217110.3390/biom14020171Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal PatternsAgata Mlynska0Jolita Gibavičienė1Otilija Kutanovaitė2Linas Senkus3Julija Mažeikaitė4Ieva Kerševičiūtė5Vygantė Maskoliūnaitė6Neda Rupeikaitė7Rasa Sabaliauskaitė8Justina Gaiževska9Karolina Suveizdė10Jan Aleksander Kraśko11Neringa Dobrovolskienė12Emilija Paberalė13Eglė Žymantaitė14Vita Pašukonienė15National Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaLife Sciences Center, Vilnius University, LT-01513 Vilnius, LithuaniaLife Sciences Center, Vilnius University, LT-01513 Vilnius, LithuaniaLife Sciences Center, Vilnius University, LT-01513 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaNational Cancer Institute, LT-08406 Vilnius, LithuaniaThe spatial distribution of tumor infiltrating lymphocytes (TILs) defines several histologically and clinically distinct immune subtypes—desert (no TILs), excluded (TILs in stroma), and inflamed (TILs in tumor parenchyma). To date, robust classification of immune subtypes still requires deeper experimental evidence across various cancer types. Here, we aimed to investigate, define, and validate the immune subtypes in melanoma by coupling transcriptional and histological assessments of the lymphocyte distribution in tumor parenchyma and stroma. We used the transcriptomic data from The Cancer Genome Atlas melanoma dataset to screen for the desert, excluded, and inflamed immune subtypes. We defined subtype-specific genes and used them to construct a subtype assignment algorithm. We validated the two-step algorithm in the qPCR data of real-world melanoma tumors with histologically defined immune subtypes. The accuracy of a classifier encompassing expression data of seven genes (immune response-related: <i>CD2</i>, <i>CD53</i>, <i>IRF1</i>, and <i>CD8B</i>; and stroma-related: <i>COL5A2</i>, <i>TNFAIP6</i>, and <i>INHBA</i>) in a validation cohort reached 79%. Our findings suggest that melanoma tumors can be classified into transcriptionally and histologically distinct desert, excluded, and inflamed subtypes. Gene expression-based algorithms can assist physicians and pathologists as biomarkers in the rapid assessment of a tumor immune microenvironment while serving as a tool for clinical decision making.https://www.mdpi.com/2218-273X/14/2/171melanomatumor-infiltrating lymphocytesbiomarkersimmune subtypesdesertexcluded
spellingShingle Agata Mlynska
Jolita Gibavičienė
Otilija Kutanovaitė
Linas Senkus
Julija Mažeikaitė
Ieva Kerševičiūtė
Vygantė Maskoliūnaitė
Neda Rupeikaitė
Rasa Sabaliauskaitė
Justina Gaiževska
Karolina Suveizdė
Jan Aleksander Kraśko
Neringa Dobrovolskienė
Emilija Paberalė
Eglė Žymantaitė
Vita Pašukonienė
Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns
Biomolecules
melanoma
tumor-infiltrating lymphocytes
biomarkers
immune subtypes
desert
excluded
title Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns
title_full Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns
title_fullStr Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns
title_full_unstemmed Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns
title_short Defining Melanoma Immune Biomarkers—Desert, Excluded, and Inflamed Subtypes—Using a Gene Expression Classifier Reflecting Intratumoral Immune Response and Stromal Patterns
title_sort defining melanoma immune biomarkers desert excluded and inflamed subtypes using a gene expression classifier reflecting intratumoral immune response and stromal patterns
topic melanoma
tumor-infiltrating lymphocytes
biomarkers
immune subtypes
desert
excluded
url https://www.mdpi.com/2218-273X/14/2/171
work_keys_str_mv AT agatamlynska definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT jolitagibaviciene definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT otilijakutanovaite definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT linassenkus definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT julijamazeikaite definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT ievakerseviciute definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT vygantemaskoliunaite definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT nedarupeikaite definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT rasasabaliauskaite definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT justinagaizevska definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT karolinasuveizde definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT janaleksanderkrasko definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT neringadobrovolskiene definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT emilijapaberale definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT eglezymantaite definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns
AT vitapasukoniene definingmelanomaimmunebiomarkersdesertexcludedandinflamedsubtypesusingageneexpressionclassifierreflectingintratumoralimmuneresponseandstromalpatterns